Epigenetic Control of Gene Expression by Bacterial Virulence Factors: History
View Latest Version
Please note this is an old version of this entry, which may differ significantly from the current revision.
Subjects: Cell Biology | Pharmacology & Pharmacy
Contributor:
Lea Denzer
,
Horst Schroten
,
Christian Schwerk

There are several levels to influence the expression of eukaryotic genes. A first level of interference is changing of the DNA’s structure on the chromatin level. Epigenetic modulation enables remodelling of the chromatin to transfer heterochromatin into euchromatin allowing transcription or vice versa. In addition, the affinity of promotors and other regulatory DNA sequences for RNA polymerases and transcription factors (TFs) can be influenced by cytosine or adenine methylation. Only a minor portion (fewer than 2%) of genes is transcribed into mRNAs, instead the majority is transferred into so called non-coding RNAs (ncRNAs). Certain long ncRNAs (lncRNAs) are also involved in epigenetic regulations. Epigenetic mechanisms are used for manipulation of gene expression in the course of several cellular processes. Here, we give an overview on the epigenetic control of gene expression by bacterial virulence factors during host cell infection.

  • epigenetics
  • gene expression
  • bacteria
  • virulence factor
  • histone modification
  • DNA methylation
  • lncRNA

The expression of genes is dependent on their accessibility for RNA polymerase II (RNA Pol II) and TFs. As approximately 147 base pairs of the DNA are wrapped around histone octamers build by the subunits H2A, H2B, H3 and H4 as well as the scaffold protein H1 to form the nucleosome, those sequences are protected from transcription [1][2][3]. Therefore, the packaging of the nucleosomes defines the chromatin state into euchromatin and heterochromatin enabling transcription or blocking it. In order to react properly to a certain stimulus, the chromatin state can be remodeled to give access to the required genes, a process called nuclear remodeling or histone modification. Enzymes posttranslationally modify the amino acids at the N-termini of the histone proteins (called histone tails) by acetylation, phosphorylation, methylation and ubiquitination in a reversible manner to modify the interaction between neighbored nucleosomes favoring an open or closed chromatin state [4][5][6]. Nucleosomes are then allowed to slide along the chromatin fiber in an ATP-dependent manner, to give access to the DNA sequence. This reveals the dual function of chromatin, to provide a natural scaffold and being part of an essential regulatory signaling network processing the incoming data to create a special transient biological output [7]. On top, established posttranslational modifications (PTMs) can be maintained beyond the initial signal and cell divisions inheriting cell type specific gene expression enabling cell lineage specification and cellular identity [7][8][9].

The enzymes responsible for the modulation of the histone tails are divided into “writers,” which attach the chemical units, “readers,” which recognize and translate them by recruitment of activating or repressing factors and “erasers,” which remove the modifications. The resulting “epigenetic code” is highly dynamic, as each established modification influences the addition or removement of other modifications that in turn influence the own stability and persistence. Moreover, epigenetic mechanisms represent the missing link between more or less stable gene expression and the impact of environmental factors on gene expression that can also cause diseases as cancer [1][10][11]. Therefore, these enzymes represent a central role in the regulation of immune responses as alterations in their activity and expression profiles leading to global changes in the histone modification pattern have been detected as cause of several chronic immune diseases as asthma, chronic obstructive pulmonary disease, colitis, systemic lupus erythematosus and rheumatoid arthritis [12][13].

Additionally, the DNA can be methylated at cytosine or adenosine residues converting them into methyl-cytosine or methyl-adenosine to cause transcriptional repression [14]. Hypermethylation dominantly occurs at CpG islands, cytosine-guanine rich regions at promotor regions, disrupting TFs and RNA polymerase binding to DNA or recruiting other co-repressors. A hypermethylated gene, that was not methylated before is therefore, not suitable for transcription and with the recruitment of further silencing-factors, will finally be silenced. This kind of modification is thought to provide a stable gene silencing that can be inherited to the next generation of cells [15][16].

Moving away from the old definition of epigenetics as hereditable stable changes at chromatin and DNA without changing its sequence, modern opinion changed towards a highly dynamic and reversible mechanism of gene regulation also enabling short term adaptions to changing environments [14]. As consequence, regulation through ncRNAs are also included to the epigenetic regulatory repertoire that can be classified according to their length into short ncRNAs (<200 nucleotides), which include miRNAs or long ncRNAs (>200 nucleotides) [17].

Manipulation at the Level of Histone Modifications

After recognition of bacterial presence by PRRs, signaling cascades activate proinflammatory cytokine expression. To improve accessibility of TFs, such as NF-κB, to the promoters of inflammatory response genes, an activating histone modification as phosphorylation of Serine 10 on histone H3 (H3S10) is established, which itself is mediated by MAPK signalling. It has been shown, that the virulence factor LPS alone is able to induce a global increase of H3S10 leading to promotion of gene expression proving the high sensitivity of the immune reaction [18].

Recent studies revealed that bacteria directly interfere with a host’s histone modifications to dampen the expression of proinflammatory cytokines by the secretion of effectors. Presence of Listeria monocytogenes induces phosphorylation of H3S10 but the bacterium is able to remove this activating phosphorylation within short time [19][20][21][22]. The secreted virulence factor Listeriolysin (LLO) mediates this mechanism and is also responsible for a global deacetylation of H3 and H4. Other bacteria, as Clostridium perfringens or Streptococcus pneumoniae, produce toxins, such as perfringolysin and pneumolysin, respectively, that belong to the same family as LLO and show also a similar effect on H3S10 phosphorylation [20]. The decreased levels of phosphorylated H3S10 and acetylated H4 at proinflammatory genes resulted in transcriptional downregulation thereby damping the immune response. As this observation is only dependent on the membrane-binding ability of LLO, it is most likely that LLO modulates the signal transduction to induce alterations in the histone modification pattern [20].

Like L. monocytogenes, Shigella flexneri is also able to inhibit H3S10 phosphorylation by secretion of phosphothreonine lyase effector OspF, which dephosphorylates MAPKs as p38 or ERK resulting in attenuated NF-κB binding at promotors of inflammatory genes [23]. Together with OspB, another effector of Shigella, OspF, interacts with the human retinoblastoma protein Rb that is capable of binding several chromatin-remodeling factors [24][25]. In this constellation, Shigella adjusts the chromatin structure at specific genes to downregulate host innate immunity.

L. monocytogenes owns another effector, which induces deacetylation on lysine 18 of histone H3 (H3K18). Thereby, Internalin B (InlB) activates the host histone deacetylase sirtuin 2 (SIRT 2), leading to repression of transcriptional start sites through occupation by SIRT 2 and following downregulation of the immune response, which could be attenuated by SIRT 2 inhibition [26]. The listerial virulence factor LntA enters the nucleus after infection of epithelial cells targeting the chromatin silencing complex component BAHD1. Together with heterochromatin protein 1 (HP1), methylated DNA-binding protein 1 (MBD1), histone deacetylases (HDAC1/2) and the KRAB-associated protein 1 (KAP1/TRIM28) that are involved in heterochromatin formation, BADH1 targets interferon-stimulated genes (ISG) for silencing by binding to their promotors [27][28]. This is inhibited by LntA, which is thought to promote chromatin-unwinding and as consequence upregulation of ISG by histone H3 acetylation. The exact mechanisms, how BAHD1 is recruited to its targets and how LntA interferes with this process has still to be investigated [29].

Another prominent histone modification is the methylation or demethylation of lysine residues, mediated by histone N-lysine methyltransferase (HKMT) or histone demethylases (HDM), respectively. Several bacteria express HKMT effectors, which enable them to directly interfere with host gene regulation as they are mimics of host chromatin modifiers. As there are many HKMT homologues in the repertoire of bacterial effectors described this mechanism seems to be a successful strategy to subvert host gene expression [30]. The nuclear effector (NUE), is secreted by Chlamydia trachomatis via a type III secretion system (T3SS) to enable its localization to the nucleus, where it might methylate H2B, H3 and H4. The homologous effectors RomA and LegAS4 secreted by Legionella pneumophila Paris and L. pneumophila Philadelphia Lp02 strains, respectively, methylate H3 to alter host transcription but target different residues [30][31]. RomA represses global transcription by methylation of histone 3 lysine 14 (H3K14), a modification that is known to compete with the activating acetylation of H3K14 [31]. Contrary to RomA, LegAS4 increases transcription of ribosomal RNA genes (rRNA) through methylation of histone 3 lysine 4 (H3K4) but if this modification is mediated by LegAS4 alone it is not clear yet [30]. Interestingly all described bacterial methyltransferases own a conserved SET (Suppressor of variegation, Enhancer of zeste and Trithorax) domain, which uses a S-adenosyl-l-methionine (SAM) methyl donor to catalyze methyl group attachment to lysine residues [30][32]. One example is the effector BtSET, secreted by Burkholderia thailandensis that localizes to the nucleolus to methylate histone H3K4 promoting transcription of rRNA genes. Some effectors are capable of more unusual modifications, for example, the effector BaSET identified in Bacillus anthracis trimethylates histone H1 but none of the core histones. This effector represses the expression of NF-κB target genes after transient overexpression in mammalian cells and its deletion results in the loss of virulence [30][31][32].

Another modification, which differs from the known mechanisms of histone modification, is represented by dimethylation of histone 3 on arginine 42 (H3R42me2), a residue critical for DNA entry/exit from the nucleosome and not located at the histone N-termini. This modification is involved in the regulation of ROS (reactive oxygen species) production, which represents a crucial host defense mechanism against bacterial pathogens [33]. Mycobacterium tuberculosis represses genes involved in ROS production by secreting Rv1988, a methytransferase able to establish H3R42me2 to increase survival in host macrophages [33]. An overview of bacteria and their effectors that are secreted to induce histone modifications is given in Table 1.

Table 1. Histone modifications established by bacterial effectors.

Target Modification Bacterium Effector Mediator Cellular Function References
H3S10 de-
phosphorylation		 L. monocytogenes LLO unknown Reduced expression of important immune regulators [20]
H3S10 de-
phosphorylation		 S. flexneri OspF MAPK   [23][34][35]
H3S10 de-
phosphorylation		 Clostridium perfringens perifringo-
lysin		 unknown unknown [20]
H3S10 de-
phosphorylation		 Streptococcus pneumoniae pneumolysin unknown unknown [20]
H3K18 deacetylation L. monocytogenes InlB c-Met induced SIRT2 recruitment
PI3K/AKT		 Reduced expression of important immune regulators [20]
H3K4 methylation L. pneumophila Philadelphia LP02 LegAS4 direct Transcriptional activation of ribosomal genes [34]
H3K4 methylation B. thaliandensis BtSET direct/NF-κΒ Transcription of rRNA genes [30][32]
H3K9 acetylation M. tuberculosis Rv3423.1 maybe direct   [36]
H3K14 methylation L. pneumophila Paris RomA direct Transcriptional repression [31]
  acteylation M. tuberculosis Rv3423.1 maybe direct   [36]
H3K23 Global deacetylation H. pylori   H3S10 dephosphorylation Differential c-Jun and HSP70 expression [37]
H1 trimethylation B. anthracis BaSET direct/NF-κΒ Transcriptional repression of NF-κΒ target genes [32]
H2B, H3, H4 methylation C. trachomatis NUE direct Transcriptional repression [38]
H3, H4 acetylation P. gingivivalis SCAFs, LPS unknown unknown  
H3 deacetylation M. tuberculosis unknown HDAC1 Silencing of inteleukin-12β, suppression of T-helper1 response [39]
H4 deacetylation L. monocytogenes LLO H3S10 de-
phosphory-
lation		 unknown [20]
H4 deacetylation M. tuberculosis unknown HDAC complex containing mammalian co-repressor Sin3A Inhibition of interferon-γ-
dependent HLA-DR gene expression		 [40]

Influencing the expression of histone modifying enzymes is another possibility to affect histone modifications in favor of bacterial survival (see Table 2). Modulation of the histone deacetylase HDAC1 appears to be most targeted by pathogens, to manipulate the key acetylation system enabling protection against eradication. Infection with Anaplasma phagocytophilum, an intracellular pathogen causing human granulocytic anaplasmosis, causes upregulation of HDAC1 leading to a globally increased HDAC activity [41]. The recruitment of HDAC1 to AT-rich chromatin sites in promotors of host defense genes is mediated by the effector ankyrin A (AnkA) resulting in the reduction of histone H3 acetylation and the suppression of target genes such as CYBB that encodes Cytochrome b-245, beta polypeptide. As this element of the phagocyte NADPH oxidase is involved in the clearance of the pathogen by neutrophils, it is preferentially targeted [42][43][44][45]. Furthermore, AnkA functionally mimics SATB1, a protein able to bind AT-rich sequences distributed across distinct chromosomes at attachment regions of the nuclear matrix. Proteins with this ability are involved in nuclear matrix attachment, spatial organization of chromatin and large-scale transcriptional regulation [44][46][47][48]. AnkA could also perform as global organizer of the neutrophil genome, thereby acting locally (cis) and at a distance (trans) to a target gene. Moreover, pathogens as Chlamydia psittaci secrete nucleomodulins (SinC) that could act like AnkA and influence anchoring factors and lamins that control the dynamics of chromatin looping and organization, as the inner nuclear membrane proteins MAN1 and LAP1 [49].

Table 2. Bacteria targeting histone modifying enzymes.

Target Modification Bacterium Effector Cellular function References
HDAC1 induction A. phagocytophilum Ankyrin A suppression of target genes as CYBB that encodes cytochrome b-245, beta polypeptide [41]
HDAC1 induction P. aeruginosa 2-Amnoacetophenone reduced expression of inflammatory cytokines and chemokines [50]
HDAC1 induction M. tuberculosis unknown Silencing of inteleukin-12β, suppression of T helper1 response [40]
HDAC2 repression P. gingivalis SCAFs Activation of genes [51][52][53][54][55]
P300 repression E. coli Proteinase NleC decreased IL-8 production [56]
HKMT repression P. gingivalis SCAFs Inhibition of heterochromatin marks [53][54][55]

Pseudomonas aeruginosa, an opportunistic pathogen that infects and colonizes inflamed airways and burn wounds, induces HDAC1 expression in human THP-1 monocytes with the help of a molecule usually used for quorum sensing, 2-aminoacetophenone [50][57]. This is followed by global histone H3K18 hypoacetylation and reduced expression of inflammatory cytokines and chemokines (e.g., TNF, IL-1b and MCP-1) resulting in dampened host defense against the bacterium.

Considering that this effect was also dampened by knockdown or inhibition of class I HDACs and the evidence that besides A. phagocytophilum and P. aeruginosa also Porphyromonas gingivalis modulates HDAC1 during infections, HDAC1 family members might play a central role in development of an epigenetic mediated tolerance against the pathogens [58]. In patients with chronic periodontitis, mRNA and protein levels of HDAC1 expression were globally increased compared to healthy individuals and colocalized with TNF expressing cells and tissues. Interestingly, epigenetic regulation mediated by P. gingivalis seems to be cell-type specific, since HDAC1 and HDAC2 are downregulated in gingival epithelial cells in vitro, while levels of acetylated histone H3 were increased in murine epithelial cells of the gingival tissue [51][59]. In addition, the host acetylation system is also often influenced by short chain fatty acids (SCAFs) produced by commensals or pathogenic bacteria as P. gingivalis (for recent reviews please refer to References [60] and [61]).

Another strategy followed by bacteria during host infection and manipulation of the epigenetic regulatory mechanisms is to proteolytically degrade histone acetyl transferase (HAT) family members. One example of bacteria using this strategy are enteropathogenic and enterohaemorrhagic Escherichia coli, which secrete the effector protein NleC, a zinc-dependent metalloproteinase targeting intracellular signaling to dampen the host inflammatory response [56]. The protein specifically binds and degrades the host HAT p300 in infected cells leading to decreased IL-8 production, an effect that can be restored by p300 overexpression. Thus, HATs and HDACs can both be targeted by pathogenic bacteria to modulate epigenetics and inflammatory gene expression in their benefit.

How to Control Host DNA Methylation

DNA methylation is another way to control gene expression. There are several enzymes called DNA-(cytosine C5)-methyltransferases (DNMTs), which establish methyl residues to cytosine or adenosine residues, respectively [61]. In contrast, the removement of DNA methylation patterns is more complex, as the modified nucleotides or DNA sequences have to be exchanged by DNA-repair mechanisms or the methylation has to be oxidized to form 5-Hydroxymethylcytosine, which can be removed by enzymes [62]. DNA methylation patterns at promotors of tumor suppressor genes had already been discovered, when first hints pointed towards an influence of bacterial inflammation on mechanisms establishing DNA-methylation patterns after Helicobacter pylori infection. In this context, among others, genes associated with cell growth (apc, p14 (ARF), p16 (INK4a)), cell adherence (cdh1, flnc, hand1, lox, hrasis, thbd, p14ARC) and DNA-repair (brca1, mgmt., hMLH1) are influenced [37][63][64][65]. Similar observations of altered DNA-methylation patterns during inflammation were made following uropathogenic E. coli, Campylobacter rectus and Mycobacterium leprae infections [66][67][68]. Still, the questions if DNA-methylation is directly induced by bacteria or is a secondary reaction by the host due to persistent inflammations, as well as the underlying mechanisms, are not completely answered yet [69].

However, several Mycoplasma species to encode mammalian DNMTs like equivalents that target cytosine-phosphate-guanine (CpG) dinucleotides to establish methylation patterns in the bacterial genome [70][71][72]. Moreover, their expression in human cells results in their translocation to the nucleus, where they set up unusual methylation patterns on the host DNA. This was shown for the DNMTs Mhy1, Mhy2 and Mhy3 expressed by Mycoplasma hyorhinis in combination with up- and downregulation of certain genes resulting in activation of proliferation specific pathways, a process that might contribute to tumor progression [70][73].

Mycobacterium tuberculosis owns an effector called Rv2699 that can enter the nucleus of THP1 cells (a monocytic cell line derived from a patient with acute monocytic leukemia) and methylate cytosines outside CpG dinucleotides. Notably, Rv2699 prefers cytosine-phosphate-adenine or cytosine-phosphate-thymine sites to generate a type of methylation that is, with few exceptions, normally not present in mammalian adult differentiated cells [74][75]. However, non-CpG methylation could lead to a more stable type of modification that persists longer in the genome of infected nondividing macrophages, offering an advantage for M tuberculosis by establishing an intracellular environment for persistence [75]. A follow up study revealed that THP1 macrophages infected with M. tuberculosis strain H37Rv created genome-wide de novo methylation patterns at non-CpG dinucleotides that included hyper- and hypomethylated regions [75][76]. Additionally, clinical isolates infecting THP1 cells may downregulate IL-6 receptor expression by hypermethylation of CpG-dinucleotides at the promoter of the IL-6 receptor gene. Still, it has to be mentioned, that the observations of M. tuberculosis induced DNA-methylation patterns depend on the infected cell type.

Another interesting bacterial induced modification of gene expression is represented by differentiated Swann cells that adapt the phenotype of progenitor stem-like cells after M. leprae infection. This is probably induced by silencing of the Sox10 gene after bacterial methylation [67]. In contrast to the decreased expression of Sox10, other genes involved in epithelial–mesenchymal transition (EMT) were demethylated and transcribed leading to the transformation of Swann cells into myofibers or smooth muscles in vitro and in vivo [77].

P. gingivalis was shown to increase the methylation of the TLR-2 promotor in gingival epithelial cells (GECs) reducing innate immunity activation and causing hyposensibility [59][78]. Besides, coinfection with Filifactor alocis, another pathogen associated with periodontitis is suggested to influence the whole cell transcriptome through impact on the nucleosome structure by reduced expression of H1 family members [53][54]. Other histone modifications induced by LPS or short chain fatty acids (SCFAs) produced by P. gingivalis are summarized in Table 1 and Table 2.

Still, there is not much known about the relation of DNA-methylation and infection and the underlying causalities [61][69]. Considering that many of these modifications are observed in the context of cancer initiation and progression, further investigation may contribute to new therapeutic agents and cancer prophylaxis.

Regulation of Host Gene Expression via lncRNAs

The role of lncRNAs during modulation of gene expression has been discovered in the recent years. Similar to mRNAs, lncRNAs are transcribed by RNA polymerase II or III, followed by splicing, 5′capping and in some cases polyadenylation at the 3′end. Contrary to mRNAs, the expression of lncRNAs is much lower and in a cell-, tissue- and developmental stage-specific manner [79].

Dependent on of their position relative to the neighboring protein-coding gene, lncRNAs are classified as sense, antisense, bidirectional, intronic or intergenic and, despite their enormous number, they were previously considered as “dark matter” or “junk” in the genome [80]. Au contraire, lncRNAs are now respected as important physiological regulators during cell homeostasis, growth, differentiation and anti-viral responses [81][82][83][84]. In addition, gene imprinting, regulation of the p53 pathway, stem cell self-renewal and differentiation and DNA damage response were reported as lncRNA controlled mechanisms [85][86][87][88].

The functionality of lncRNAs is not restricted to the neighbored protein-coding gene (in cis), in contrast they are also able to act in trans to regulate gene expression across chromosomes. In this context, lncRNAs regulate different processes as chromatin remodeling, transcription and post-transcriptional regulation via their capacity as signals, decoys, guides and scaffolds [89][90]. Interestingly, another origin of lncRNAs is the expression of pseudogenes and gaining Influence over the expression of pseudogenes could, therefore, provide a possibility to control infectious responses [91].

Immune regulation through lncRNAs has already been known after viral infections but recent research indicates its involvement also whilst fighting bacteria [92]. In that context, 76 enhancer RNAs (eRNAs), 40 canonical lncRNAs, 65 antisense lncRNAs and 35 regions of bidirectional transcription are differentially expressed in human monocytes after LPS stimulation [93]. LPS stimulation alone induces a differential expression of about 27 lncRNAs leading to histone trimethylation or acetylation of neighboring genes after de-regulation, pointing towards their regulatory influence during the innate-immune response [94]. The observation, that 44% of total lncRNAs varied in their expression after Salmonella infection in HeLa cells could foster these results and substantiate them by a function in the early phase of infection as sensitive markers for pathogen activity [95]. In line with this, the lncRNA HOTAIR that contributes to transcriptional repression of HOX genes also promotes inflammation in mice cardiomyocytes by TNF-α production mediated through phosphorylation of p65 protein and NF-κB activation after LPS induced sepsis [96][97].

Long intergenic non-coding RNAs (lincRNAs) are a subtype of lncRNAs, as they are expressed from intergenic regions. In response to an LPS stimulus, bone-marrow dendritic cells expressed about 20 lincRNAs with the majority being dependent on NF-κB activity, including lincRNA-Cox2, which is also upregulated in bone marrow-derived macrophages following L. monocytognes infection [98][99]. Additionally, bacteria sabotage lncRNA activity, as BCG (attenuated strain M. bovis bacillus Calmette-Guérin BCG) infected macrophages repress the expression of 11 lncRNAs that are not dampened by infection with heat activated bacteria [100]. Still, possible subversion of lncRNA-mediated inflammatory regulation needs to be further investigated.

This entry is adapted from the peer-reviewed paper 10.3390/ijms21103730

References

  1. Tony Kouzarides; Chromatin Modifications and Their Function. Cell 2007, 128, 693-705, 10.1016/j.cell.2007.02.005.
  2. Diana C Hargreaves; Gerald R. Crabtree; ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Research 2011, 21, 396-420, 10.1038/cr.2011.32.
  3. Karolin Luger; Armin W. Mäder; Robin K. Richmond; David F. Sargent; Timothy J. Richmond; Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 1997, 389, 251-260, 10.1038/38444.
  4. Elias Cornejo; Philipp Schlaermann; Shaeri Mukherjee; How to rewire the host cell: A home improvement guide for intracellular bacteria. Journal of Cell Biology 2017, 216, 3931-3948, 10.1083/jcb.201701095.
  5. Hélène Bierne; Pascale Cossart; When bacteria target the nucleus: the emerging family of nucleomodulins. Cellular Microbiology 2012, 14, 622-633, 10.1111/j.1462-5822.2012.01758.x.
  6. J. C. Van Wolfswinkel; Rene F Ketting; The role of small non-coding RNAs in genome stability and chromatin organization. Journal of Cell Science 2010, 123, 1825-1839, 10.1242/jcs.061713.
  7. Benjamin Lee; Louis C. Mahadevan; Stability of histone modifications across mammalian genomes: Implications for ‘epigenetic’ marking. Journal of Cellular Biochemistry 2009, 108, 22-34, 10.1002/jcb.22250.
  8. Stuart L. Schreiber; Bradley E. Bernstein; Signaling network model of chromatin. Cell 2002, 111, 771-778, 10.1016/s0092-8674(02)01196-0.
  9. Edwin Smith; Ali Shilatifard; The Chromatin Signaling Pathway: Diverse Mechanisms of Recruitment of Histone-Modifying Enzymes and Varied Biological Outcomes. Molecular Cell 2010, 40, 689-701, 10.1016/j.molcel.2010.11.031.
  10. Thomas R. Cech; Joan A. Steitz; The Noncoding RNA Revolution—Trashing Old Rules to Forge New Ones. Cell 2014, 157, 77-94, 10.1016/j.cell.2014.03.008.
  11. Thomas Mikeska; Jeffrey M Craig; DNA Methylation Biomarkers: Cancer and Beyond. Genes 2014, 5, 821-864, 10.3390/genes5030821.
  12. Aleksander M Grabiec; Paul-Peter Tak; Kris A Reedquist; Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on?. Arthritis Research & Therapy 2008, 10, 226, 10.1186/ar2489.
  13. Zimu Zhang; Rongxin Zhang; Epigenetics in autoimmune diseases: Pathogenesis and prospects for therapy. Autoimmunity Reviews 2015, 14, 854-863, 10.1016/j.autrev.2015.05.008.
  14. Farzam Vaziri; Samira Tarashi; Abolfazl Fateh; Seyed Davar Siadat; New insights of Helicobacter pylori host-pathogen interactions: The triangle of virulence factors, epigenetic modifications and non-coding RNAs. World Journal of Clinical Cases 2018, 6, 64-73, 10.12998/wjcc.v6.i5.64.
  15. Peter A. Jones; The Role of DNA Methylation in Mammalian Epigenetics. Science 2001, 293, 1068-1070, 10.1126/science.1063852.
  16. Yukie Yoda; Hideyuki Takeshima; Tohru Niwa; Jeong Goo Kim; Takayuki Ando; Ryoji Kushima; Toshiro Sugiyama; Hitoshi Katai; Hirokazu Noshiro; Toshikazu Ushijima; et al. Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. Gastric Cancer 2014, 18, 65-76, 10.1007/s10120-014-0348-0.
  17. Mélodie Duval; Pascale Cossart; Alice Lebreton; Mammalian microRNAs and long noncoding RNAs in the host-bacterial pathogen crosstalk. Seminars in Cell & Developmental Biology 2017, 65, 11-19, 10.1016/j.semcdb.2016.06.016.
  18. Saccani, S.; Pantano, S.; Natoli, G; p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat. Immunol. 2002, 3, 69–75, .
  19. Melanie A. Hamon; Pascale Cossart; Histone Modifications and Chromatin Remodeling during Bacterial Infections. Cell Host & Microbe 2008, 4, 100-109, 10.1016/j.chom.2008.07.009.
  20. Melanie A. Hamon; Eric Batsché; Béatrice Régnault; To Nam Tham; Stéphanie Seveau; Christian Muchardt; Pascale Cossart; Histone modifications induced by a family of bacterial toxins. Proceedings of the National Academy of Sciences 2007, 104, 13467-13472, 10.1073/pnas.0702729104.
  21. Bernd Schmeck; Wiebke Beermann; Vincent Van Laak; Janine Zahlten; Bastian Opitz; Martin Witzenrath; Andreas C. Hocke; Trinad Chakraborty; Michael Kracht; Simone Rosseau; et al. Intracellular bacteria differentially regulated endothelial cytokine release by MAPK-dependent histone modification. The Journal of Immunology 2005, 175, 2843-2850, 10.4049/jimmunol.175.5.2843.
  22. Bastian Opitz; Anja Püschel; Wiebke Beermann; Andreas C. Hocke; Stefanie Förster; Bernd Schmeck; Vincent Van Laak; Trinad Chakraborty; Norbert Suttorp; Stefan Hippenstiel; et al. Listeria monocytogenes activated p38 MAPK and induced IL-8 secretion in a nucleotide-binding oligomerization domain 1-dependent manner in endothelial cells.. The Journal of Immunology 2006, 176, 484-490, 10.4049/jimmunol.176.1.484.
  23. Arbibe, L.; Kim, D.W.; Batsche, E.; Pedron, T.; Mateescu, B.; Muchardt, C.; Parsot, C.; Sansonetti, P.J; An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat. Immunol. 2007, 8, 47–56, .
  24. Damian F. Brennan; David Barford; Eliminylation: a post-translational modification catalyzed by phosphothreonine lyases. Trends in Biochemical Sciences 2009, 34, 108-114, 10.1016/j.tibs.2008.11.005.
  25. Daniel V. Zurawski; Karen L. Mumy; Christina S. Faherty; Beth A. McCormick; Anthony T. Maurelli; Shigella flexneritype III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein. Molecular Microbiology 2009, 71, 350-368, 10.1111/j.1365-2958.2008.06524.x.
  26. Haig A. Eskandarian; Francis Impens; Marie-Anne Nahori; Guillaume Soubigou; Jean-Yves Coppée; Pascale Cossart; Melanie A. Hamon; A Role for SIRT2-Dependent Histone H3K18 Deacetylation in Bacterial Infection. Science 2013, 341, 1238858-1238858, 10.1126/science.1238858.
  27. Hélène Bierne; To Nam Tham; Eric Batsche; Anne Dumay; Morwenna Leguillou; Sophie Kernéis-Golsteyn; Béatrice Regnault; Jacob Seeler; Christian Muchardt; Jean Feunteun; et al. Human BAHD1 promotes heterochromatic gene silencing. Proceedings of the National Academy of Sciences 2009, 106, 13826-13831, 10.1073/pnas.0901259106.
  28. Paul Cotter; Faculty Opinions recommendation of A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response.. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature 2011, 331, 1319–1321, 10.3410/f.9077956.9654054.
  29. Hélène Bierne; Renaud Pourpre; Bacterial Factors Targeting the Nucleus: The Growing Family of Nucleomodulins. Toxins 2020, 12, 220, 10.3390/toxins12040220.
  30. Ting Li; Qiuhe Lu; Guolun Wang; Hao Xu; Huanwei Huang; Tao Cai; Biao Kan; Jianning Ge; Feng Shao; SET‐domain bacterial effectors target heterochromatin protein 1 to activate host rDNA transcription. EMBO reports 2013, 14, 733-740, 10.1038/embor.2013.86.
  31. Monica Rolando; Serena Sanulli; Christophe Rusniok; Laura Gomez-Valero; Clement Bertholet; Tobias Sahr; Raphaël Margueron; Carmen Buchrieser; Legionella pneumophila Effector RomA Uniquely Modifies Host Chromatin to Repress Gene Expression and Promote Intracellular Bacterial Replication. Cell Host & Microbe 2013, 13, 395-405, 10.1016/j.chom.2013.03.004.
  32. Mujtaba, S.; Winer, B.Y.; Jaganathan, A.; Patel, J.; Sgobba, M.; Schuch, R.; Gupta, Y.K.; Haider, S.; Wang, R.; Fischetti, V.A; et al. Anthrax SET protein: A potential virulence determinant that epigenetically represses NF-kappaB activation in infected macrophages. J. Biol. Chem. 2013, 288, 23458–23472, .
  33. Imtiyaz Yaseen; Prabhjot Kaur; Vinay Kumar Nandicoori; Sanjeev Khosla; Mycobacteria modulate host epigenetic machinery by Rv1988 methylation of a non-tail arginine of histone H3. Nature Communications 2015, 6, 1–13, 10.1038/ncomms9922.
  34. Hongtao Li; Hao Xu; Yan Zhou; Jie Zhang; Chengzu Long; Shuqin Li; She Chen; Jian-Min Zhou; Feng Shao; The Phosphothreonine Lyase Activity of a Bacterial Type III Effector Family. Science 2007, 315, 1000-1003, 10.1126/science.1138960.
  35. Yongqun Zhu; Hongtao Li; Chengzu Long; Liyan Hu; Hao Xu; Liping Liu; She Chen; Da-Cheng Wang; Feng Shao; Structural Insights into the Enzymatic Mechanism of the Pathogenic MAPK Phosphothreonine Lyase. Molecular Cell 2007, 28, 899-913, 10.1016/j.molcel.2007.11.011.
  36. Leny Jose; Ranjit Ramachandran; Raghu Bhagavat; Roshna Lawrence Gomez; Aneesh Chandran; Sajith Raghunandanan; Ramakrishnapillai Vyomakesannair Omkumar; Nagasuma Chandra; Sathish Mundayoor; Ramakrishnan Ajay Kumar; et al. Hypothetical protein Rv3423.1 of Mycobacterium tuberculosis is a histone acetyltransferase. The FEBS Journal 2016, 283, 265-281, 10.1111/febs.13566.
  37. Song-Ze Ding; Wolfgang Fischer; Maria Kaparakis-Liaskos; George Liechti; D. Scott Merrell; Patrick A. Grant; Richard L. Ferrero; Sheila E. Crowe; Rainer Haas; Masanori Hatakeyama; et al. Helicobacter pylori-Induced Histone Modification, Associated Gene Expression in Gastric Epithelial Cells, and Its Implication in Pathogenesis. PLOS ONE 2010, 5, e9875, 10.1371/journal.pone.0009875.
  38. Meghan E. Pennini; Stéphanie Perrinet; Alice Dautry-Varsat; Agathe Subtil; Histone Methylation by NUE, a Novel Nuclear Effector of the Intracellular Pathogen Chlamydia trachomatis. PLOS Pathogens 2010, 6, e1000995, 10.1371/journal.ppat.1000995.
  39. Aneesh Chandran; Cecil Antony; Leny Jose; Sathish Mundayoor; Krishnamurthy Natarajan; Ramakrishnan Ajay Kumar; Mycobacterium tuberculosis Infection Induces HDAC1-Mediated Suppression of IL-12B Gene Expression in Macrophages. Frontiers in Microbiology 2015, 5, 98, 10.3389/fcimb.2015.00090.
  40. Yue Wang; Heather M Curry; Bruce S Zwilling; William P Lafuse; Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. The Journal of Immunology 2005, 174, 5687–5694, .
  41. Jose Carlos Garcia-Garcia; Nicole C. Barat; Sarah J. Trembley; J. Stephen Dumler; Epigenetic Silencing of Host Cell Defense Genes Enhances Intracellular Survival of the Rickettsial Pathogen Anaplasma phagocytophilum. PLOS Pathogens 2009, 5, e1000488, 10.1371/journal.ppat.1000488.
  42. Jose Carlos Garcia-Garcia; Kristen Rennoll-Bankert; Shaaretha Pelly; Aaron Milstone; J. Stephen Dumler; Silencing of Host Cell CYBB Gene Expression by the Nuclear Effector AnkA of the Intracellular Pathogen Anaplasma phagocytophilum. Infection and Immunity 2009, 77, 2385-2391, 10.1128/iai.00023-09.
  43. Kristen Rennoll-Bankert; J. Stephen Dumler; Lessons from Anaplasma phagocytophilum: Chromatin Remodeling by Bacterial Effectors. Infectious Disorders - Drug Targets 2012, 12, 380-387, 10.2174/187152612804142242.
  44. Kristen Rennoll-Bankert; Jose Carlos Garcia-Garcia; Sara H. Sinclair; J. Stephen Dumler; Chromatin-bound bacterial effector ankyrin A recruits histone deacetylase 1 and modifies host gene expression. Cellular Microbiology 2015, 17, 1640-1652, 10.1111/cmi.12461.
  45. Park, J.; Kim, K.J.; Choi, K.S.; Grab, D.J.; Dumler, J.S; Anaplasma phagocytophilum AnkA binds to granulocyte DNA and nuclear proteins. Cell. Microbiol. 2004, 6, 743–751, .
  46. Dumler, J.S.; Sinclair, S.H.; Pappas-Brown, V.; Shetty, A.C; Genome-Wide Anaplasma phagocytophilum AnkA-DNA Interactions Are Enriched in Intergenic Regions and Gene Promoters and Correlate with Infection-Induced Differential Gene Expression. Front. Cell. Infect. Microbiol. 2016, 6, 97, .
  47. Terumi Kohwi-Shigematsu; Terumi Kohwi-Shigematsu; Keiko Takahashi; Hunter W. Richards; Stephen Ayers; Hye-Jung Han; Shutao Cai; SATB1-mediated functional packaging of chromatin into loops. Methods 2012, 58, 243-254, 10.1016/j.ymeth.2012.06.019.
  48. Tian-Yun Wang; Zhong-Min Han; Yu-Rong Chai; Jun-He Zhang; A mini review of MAR-binding proteins. Molecular Biology Reports 2010, 37, 3553-3560, 10.1007/s11033-010-0003-8.
  49. Sergio A. Mojica; Kelley M. Hovis; Matthew B. Frieman; Bao Tran; Ru-Ching Hsia; Jacques Ravel; Clifton Jenkins-Houk; Katherine L. Wilson; Patrik M. Bavoil; SINC, a type III secreted protein of Chlamydia psittaci, targets the inner nuclear membrane of infected cells and uninfected neighbors. Molecular Biology of the Cell 2015, 26, 1918-1934, 10.1091/mbc.E14-11-1530.
  50. Arunava Bandyopadhaya; Amy Tsurumi; Damien Maura; Kate L. Jeffrey; Laurence G Rahme; A quorum-sensing signal promotes host tolerance training through HDAC1-mediated epigenetic reprogramming.. Nature Microbiology 2016, 1, 1-9, 10.1038/nmicrobiol.2016.174.
  51. Yin, L.; Chung, W.O; Epigenetic regulation of human beta-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria. Mucosal Immunol. 2011, 4, 409–419, .
  52. Kenichi Imai; Harumi Inoue; Muneaki Tamura; Marni E. Cueno; Hiroko Inoue; O. Takeichi; Kaoru Kusama; Ichiro Saito; Kuniyasu Ochiai; The periodontal pathogen Porphyromonas gingivalis induces the Epstein–Barr virus lytic switch transactivator ZEBRA by histone modification. Biochimie 2012, 94, 839-846, 10.1016/j.biochi.2011.12.001.
  53. A. Wilson Aruni; Arunima Mishra; Yuetan Dou; Ozioma Chioma; Brittany N. Hamilton; Hansel Fletcher; Filifactor alocis--a new emerging periodontal pathogen.. Microbes and Infection 2015, 17, 517-530, 10.1016/j.micinf.2015.03.011.
  54. A. Wilson Aruni; Kangling Zhang; Yuetan Dou; Hansel Fletcher; Proteome Analysis of Coinfection of Epithelial Cells with Filifactor alocis and Porphyromonas gingivalis Shows Modulation of Pathogen and Host Regulatory Pathways. Infection and Immunity 2014, 82, 3261-3274, 10.1128/iai.01727-14.
  55. Barros, S.P.; Offenbacher, S; Modifiable risk factors in periodontal disease: Epigenetic regulation of gene expression in the inflammatory response. Periodontology 2000 2014, 64, 95–110, .
  56. Stephanie R. Shames; Amit Bhavsar; Matthew Croxen; Robyn J. Law; Shinghung Mak; Wanyin Deng; Yuling Li; Roza Bidshari; Carmen L. De Hoog; Leonard J. Foster; et al. The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300. Cellular Microbiology 2011, 13, 1542-1557, 10.1111/j.1462-5822.2011.01640.x.
  57. Márió Gajdács; Carbapenem-Resistant but Cephalosporin-Susceptible Pseudomonas aeruginosa in Urinary Tract Infections: Opportunity for Colistin Sparing. Antibiotics 2020, 9, 153, 10.3390/antibiotics9040153.
  58. Melissa Cantley; A. A. S. S. K. Dharmapatni; Kent Algate; T. N. Crotti; P. M. Bartold; D R Haynes; Class I and II histone deacetylase expression in human chronic periodontitis gingival tissue. Journal of Periodontal Research 2015, 51, 143-151, 10.1111/jre.12290.
  59. M.D. Martins; Luciana O. Almeida; Carlos Garaicoa-Pazmiño; J.M. Le; C.H. Squarize; N. Inohara; William V. Giannobile; Y. Jiao; L. Larsson; R.M. Castilho; et al. Epigenetic Modifications of Histones in Periodontal Disease. Journal of Dental Research 2015, 95, 215-222, 10.1177/0022034515611876.
  60. Grabiec, A.M.; Potempa, J; Epigenetic regulation in bacterial infections: Targeting histone deacetylases. Crit. Rev. Microbiol. 2018, 44, 336–350, .
  61. Hans Helmut Niller; Roland Masa; Annamária Venkei; Sándor Mészáros; Janos Minarovits; Pathogenic mechanisms of intracellular bacteria. Current Opinion in Infectious Diseases 2017, 30, 309-315, 10.1097/qco.0000000000000363.
  62. Susan C. Wu; Yi Zhang; Active DNA demethylation: many roads lead to Rome. Nature Reviews Molecular Cell Biology 2010, 11, 607-620, 10.1038/nrm2950.
  63. Gerardo Nardone; Debora Compare; Patrizia De Colibus; Germana De Nucci; Alba Rocco; Helicobacter pylori and Epigenetic Mechanisms Underlying Gastric Carcinogenesis. Digestive Diseases 2007, 25, 225-229, 10.1159/000103890.
  64. Juliana Santos; Marcelo Ribeiro; Epigenetic regulation of DNA repair machinery inHelicobacter pylori-induced gastric carcinogenesis. World Journal of Gastroenterology 2015, 21, 9021-9037, 10.3748/wjg.v21.i30.9021.
  65. Ramakrishnan Sitaraman; Helicobacter pylori DNA methyltransferases and the epigenetic field effect in cancerization. Frontiers in Microbiology 2014, 5, 115, 10.3389/fmicb.2014.00115.
  66. Y.A. Bobetsis; S.P. Barros; D.M. Lin; J.R. Weidman; D.C. Dolinoy; R.L. Jirtle; K.A. Boggess; J.D. Beck; S. Offenbacher; Bacterial infection promotes DNA hypermethylation. Journal of Dental Research 2007, 86, 169-174, 10.1177/154405910708600212.
  67. Toshihiro Masaki; Jinrong Qu; Justyna Cholewa-Waclaw; Karen Burr; Ryan Raaum; Anura Rambukkana; Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection. Cell 2013, 152, 51-67, 10.1016/j.cell.2012.12.014.
  68. Cornelia Tolg; Nesrin Sabha; Rene Cortese; Trupti Panchal; Alya Ahsan; Ashraf T Soliman; Karen J Aitken; Arturas Petronis; Darius J. Bägli; Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. Laboratory Investigation 2011, 91, 825-836, 10.1038/labinvest.2010.197.
  69. J. Minarovits; Microbe-induced epigenetic alterations in host cells: The coming era of patho-epigenetics of microbial infections. Acta Microbiologica et Immunologica Hungarica 2009, 56, 1-19, 10.1556/amicr.56.2009.1.1.
  70. Andrei V. Chernov; Leticia Reyes; Scott Peterson; Alex Y. Strongin; Depletion of CG-Specific Methylation in Mycoplasma hyorhinis Genomic DNA after Host Cell Invasion. PLOS ONE 2015, 10, e0142529, 10.1371/journal.pone.0142529.
  71. Wenyi Luo; Anh-Hue T. Tu; Zuhua Cao; Huilan Yu; Kevin Dybvig; Identification of an isoschizomer of the HhaI DNA methyltransferase in Mycoplasma arthritidis. FEMS Microbiology Letters 2009, 290, 195-198, 10.1111/j.1574-6968.2008.01428.x.
  72. Marek Wojciechowski; Honorata Czapinska; Matthias Bochtler; CpG underrepresentation and the bacterial CpG-specific DNA methyltransferase M.MpeI. Proceedings of the National Academy of Sciences 2013, 110, 105-110, 10.1073/pnas.1207986110.
  73. Andrei V. Chernov; Leticia Reyes; Zhenkang Xu; Beatriz Gonzalez; Georgiy Golovko; Scott Peterson; Manuel Perucho; Yuriy Fofanov; Alex Y. Strongin; Mycoplasma CG- and GATC-specific DNA methyltransferases selectively and efficiently methylate the host genome and alter the epigenetic landscape in human cells. Epigenetics 2015, 10, 303-318, 10.1080/15592294.2015.1020000.
  74. Sara E. Pinney; Mammalian Non-CpG Methylation: Stem Cells and Beyond. Biology 2014, 3, 739-751, 10.3390/biology3040739.
  75. Garima Sharma; Sandeep Upadhyay; M. Srilalitha; Vinay Kumar Nandicoori; Sanjeev Khosla; The interaction of mycobacterial protein Rv2966c with host chromatin is mediated through non-CpG methylation and histone H3/H4 binding. Nucleic Acids Research 2015, 43, 3922-3937, 10.1093/nar/gkv261.
  76. Garima Sharma; Divya Tej Sowpati; Prakruti Singh; Mehak Zahoor Khan; Rakesh Ganji; Sandeep Upadhyay; Sharmistha Banerjee; Vinay Kumar Nandicoori; Sanjeev Khosla; Genome-wide non-CpG methylation of the host genome during M. tuberculosis infection. Scientific Reports 2016, 6, 25006, 10.1038/srep25006.
  77. Samuel Hess; Anura Rambukkana; Bacterial-induced cell reprogramming to stem cell-like cells: new premise in host-pathogen interactions. Current Opinion in Microbiology 2015, 23, 179-188, 10.1016/j.mib.2014.11.021.
  78. M. Benakanakere; M. Abdolhosseini; K. Hosur; Livia Finoti; Denis F. Kinane; TLR2 promoter hypermethylation creates innate immune dysbiosis. Journal of Dental Research 2015, 94, 183-191, 10.1177/0022034514557545.
  79. Djebali, S.; Davis, C.A.; Merkel, A.; Dobin, A.; Lassmann, T.; Mortazavi, A.; Tanzer, A.; Lagarde, J.; Lin, W.; Schlesinger, F.; et al. Landscape of transcription in human cells. Nature 2012, 489, 101–108, .
  80. Doolittle, W.F; Is junk DNA bunk? A critique of ENCODE. Proc. Natl. Acad. Sci. USA 2013, 110, 5294–5300, .
  81. Ines Ambite; Daniel S. C. Butler; Christoph Stork; Jenny Grönberg-Hernández; Bela Köves; Jaroslaw Zdziarski; Jerome Pinkner; Scott J. Hultgren; Ulrich Dobrindt; Björn Wullt; et al. Fimbriae reprogram host gene expression – Divergent effects of P and type 1 fimbriae. PLOS Pathogens 2019, 15, e1007671, 10.1371/journal.ppat.1007671.
  82. Alessandro Fatica; Irene Bozzoni; Long non-coding RNAs: new players in cell differentiation and development. Nature Reviews Microbiology 2014, 15, 7-21, 10.1038/nrg3606.
  83. Wenqian Hu; Juan R Alvarez-Dominguez; H F Lodish; Regulation of mammalian cell differentiation by long non‐coding RNAs. EMBO reports 2012, 13, 971-983, 10.1038/embor.2012.145.
  84. Orly Wapinski; Howard Y Chang; Long noncoding RNAs and human disease. Trends in Cell Biology 2011, 21, 354-361, 10.1016/j.tcb.2011.04.001.
  85. Paulina A. Latos; Florian M. Pauler; Martha V. Koerner; H. Başak Şenergin; Quanah J. Hudson; Roman R. Stocsits; Wolfgang Allhoff; Stefan H. Stricker; Ruth M. Klement; Katarzyna E. Warczok; et al. Airn Transcriptional Overlap, But Not Its lncRNA Products, Induces Imprinted Igf2r Silencing. Science 2012, 338, 1469-1472, 10.1126/science.1228110.
  86. Qian Liu; Jianguo Huang; Nanjiang Zhou; Ziqiang Zhang; Ali Zhang; Zhaohui Lu; Fangting Wu; Yin-Yuan Mo; LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Research 2013, 41, 4976-4987, 10.1093/nar/gkt182.
  87. Vivek Sharma; Simran Khurana; Nard Kubben; Kotb Abdelmohsen; Philipp Oberdoerffer; Myriam Gorospe; Tom Misteli; A BRCA 1‐interacting lnc RNA regulates homologous recombination. EMBO reports 2015, 16, 1520-1534, 10.15252/embr.201540437.
  88. Yul W Yang; Ryan A. Flynn; Yong Chen; Kun Qu; Bingbing Wan; Kevin C Wang; Ming Lei; Howard Y Chang; Essential role of lncRNA binding for WDR5 maintenance of active chromatin and embryonic stem cell pluripotency. eLife 2014, 3, e02046, 10.7554/eLife.02046.
  89. Bonasio, R.; Shiekhattar, R; Regulation of Spermatogenesis by Noncoding RNAs. Annu. Rev. Genet. 2014, 48, 433–455, .
  90. Kevin C. Wang; Howard Y. Chang; Molecular Mechanisms of Long Noncoding RNAs. Molecular Cell 2011, 43, 904-914, 10.1016/j.molcel.2011.08.018.
  91. Nicole A Rapicavoli; Kun Qu; Jiajing Zhang; Megan E. Mikhail; Remi-Martin Laberge; Howard Y Chang; A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. eLife 2013, 2, e00762, 10.7554/elife.00762.
  92. Yao-Zhong Ding; Zhong-Wang Zhang; Ya-Li Liu; Chong-Xu Shi; Jie Zhang; Yongguang Zhang; Relationship of long noncoding RNA and viruses. Genomics 2016, 107, 150-154, 10.1016/j.ygeno.2016.01.007.
  93. Nicholas E. Iiott; James A. Heward; Benoît Roux; Eleni Tsitsiou; Peter S. Fenwick; Luca Lenzi; Ian Goodhead; Christiane Hertz-Fowler; Andreas Heger; Neil Hall; et al. Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes. Nature Communications 2014, 5, 1-14, 10.1038/ncomms4979.
  94. Ai-Ping Mao; Jun Shen; Zhixiang Zuo; Expression and regulation of long noncoding RNAs in TLR4 signaling in mouse macrophages.. BMC Genomics 2015, 16, 45, 10.1186/s12864-015-1270-5.
  95. Alexander J. Westermann; Konrad U. Förstner; Fabian Amman; Lars Barquist; Yanjie Chao; Leon N. Schulte; Lydia Müller; Richard Reinhardt; Peter F Stadler; Jörg Vogel; et al. Dual RNA-seq unveils noncoding RNA functions in host–pathogen interactions. Nature 2016, 529, 496-501, 10.1038/nature16547.
  96. John L Rinn; Michael Kertesz; Jordon Wang; Sharon L. Squazzo; Xiao Xu; Samantha A. Brugmann; L Henry Goodnough; Jill A. Helms; P J Farnham; Eran Segal; et al. Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs. Cell 2007, 129, 1311-1323, 10.1016/j.cell.2007.05.022.
  97. Wu, H.; Liu, J.; Li, W.; Liu, G.; Li, Z; LncRNA-HOTAIR promotes TNF-alpha production in cardiomyocytes of LPS-induced sepsis mice by activating NF-kappaB pathway. Biochem. Biophys. Res. Commun. 2016, 471, 240–246, .
  98. Susan Carpenter; Daniel Aiello; Maninjay K. Atianand; Emiliano Ricci; Pallavi Gandhi; Lisa L. Hall; Meg Byron; Brian Monks; Meabh Henry-Bezy; Jeanne B. Lawrence; et al. A Long Noncoding RNA Mediates Both Activation and Repression of Immune Response Genes. Science 2013, 341, 789-792, 10.1126/science.1240925.
  99. Mitchell Guttman; Ido Amit; Manuel Garber; Courtney French; Michael F. Lin; David M. Feldser; Maite Huarte; Or Zuk; Bryce W. Carey; John P. Cassady; et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458, 223-227, 10.1038/nature07672.
  100. Kamlesh Ganesh Pawar; Carlos Hanisch; Sergio Eliseo Palma Vera; Ralf Einspanier; Soroush Sharbati; Down regulated lncRNA MEG3 eliminates mycobacteria in macrophages via autophagy. Scientific Reports 2016, 6, 1-13, 10.1038/srep19416.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
This entry is offline, you can click here to edit this entry!
Video Production Service
Feedback